# Deramaxx Deracoxib Dogs: Post-Surgery Pain Dose Guide ## Key Takeaways - Deracoxib (Deramaxx) is indicated for postoperative pain and inflammation in dogs, typically administered orally at 1-2 mg/kg once daily. Clinical trials support its use in soft tissue and dental surgeries, often initiated preoperatively and continued for a total of 3 days. - The primary mechanism of deracoxib is selective COX-2 inhibition, aiming to reduce prostaglandins mediating pain and inflammation while theoretically sparing COX-1's gastroprotective functions. However, gastrointestinal ulceration and perforation remain significant risks, even at labeled doses. - Contraindications include concurrent use with other NSAIDs or corticosteroids, which dramatically increases the risk of severe gastrointestinal complications. Caution is advised in dogs with pre-existing renal, hepatic, or gastrointestinal disease. - Common adverse effects include vomiting, diarrhea, and decreased appetite; serious effects can include GI ulceration, perforation, and renal tubular degeneration, particularly at higher doses or in susceptible individuals. - Administration with food is recommended to mitigate gastrointestinal upset, and owners must monitor closely for signs of adverse effects such as melena, hematemesis, lethargy, or jaundice, contacting their veterinarian immediately if observed. - Preoperative administration of deracoxib is crucial for preemptive analgesia, reducing the initial inflammatory response and subsequent pain amplification, thereby improving overall pain management and potentially reducing the need for rescue analgesia. --- **Direct Answer:** For postoperative pain in dogs, deracoxib (Deramaxx) is typically administered at a dose of 1 to 2 mg/kg (0.45 to 0.91 mg/lb) once daily by mouth. In clinical trials for soft tissue and dental surgery, this dose was given as a preoperative treatment and continued once daily for 2 additional days, for a total of 3 days of therapy. Your veterinarian will provide the exact prescription and specific instructions based on your [dog](/knowledge/veterinary-medicine/clinical-methods/dog)'s individual health status and the type of surgery performed. **Owner Triage Summary:** If your dog has just had surgery and you have been prescribed Deramaxx, give the first dose exactly as directed by your vet, usually with food. Watch your dog closely for any signs of gastrointestinal upset, such as vomiting, diarrhoea, or a sudden loss of appetite. If you notice these signs, or if your dog seems unusually lethargic, stop the medication and contact your veterinarian immediately. Do not give your dog any other NSAIDs (like carprofen, meloxicam, or aspirin) or corticosteroids while they are on Deramaxx, as this combination can be dangerous. Never adjust the dose or extend the treatment duration without explicit veterinary guidance. ## At a Glance: Deramaxx for Post-Surgical Pain This table provides a quick clinical reference for the use of deracoxib in managing postoperative pain. It is a summary of published data and is not a substitute for a veterinary prescription. | Parameter | Clinical Recommendation (Based on Published Studies) | | :--- | :--- | | **Active Ingredient** | Deracoxib (a selective COX-2 inhibitor NSAID) [1] | | **Approved Canine Use** | Relief of pain and inflammation associated with orthopedic surgery and osteoarthritis [1]. Studies also support use in soft tissue and dental surgery [2][3]. | | **Standard Post-Op Dose** | 1 to 2 mg/kg, administered orally, once daily [2][3]. | | **Typical Duration for Acute Pain** | 3 days (given preoperatively, then once daily for 2 more days) [2][3]. | | **Administration** | By mouth (PO), ideally with food to help reduce the risk of gastrointestinal upset. | | **Onset of Action** | Clinical studies show significant improvement in analgesia when administered perioperatively [2][3]. | | **Key Contraindications** | Do not use with other NSAIDs or corticosteroids. Use with caution in dogs with pre-existing kidney, liver, or gastrointestinal disease [1][4][5]. | | **Common Adverse Effects** | Vomiting, diarrhoea, decreased appetite, lethargy [2][3][4]. | | **Serious Adverse Effects** | Gastrointestinal ulceration and perforation, renal tubular degeneration (at higher doses) [1][4][5]. | ## Understanding Deracoxib and Its Role in Pain Management Deracoxib is a non-steroidal anti-inflammatory drug (NSAID) that belongs to the coxib class. Its primary mechanism of action is the selective inhibition of the cyclooxygenase-2 (COX-2) enzyme. This enzyme is responsible for producing prostaglandins, which are chemical messengers that mediate pain, inflammation, and fever. By selectively targeting COX-2, deracoxib aims to provide effective pain relief while potentially sparing the COX-1 enzyme, which helps maintain the protective lining of the gastrointestinal tract and supports normal platelet function [1][6]. This COX-2 selectivity is a key reason why deracoxib is often chosen for managing acute surgical pain. It allows for potent anti-inflammatory and analgesic effects at the surgical site while theoretically reducing the risk of certain side effects (like gastric ulceration) compared to older, non-selective NSAIDs. However, it is critical to understand that no NSAID, including deracoxib, is completely free of risk. Research has demonstrated that even at labeled doses, deracoxib can cause significant gastrointestinal issues in some dogs [4][5]. ## Evidence-Based Management: Deracoxib for Post-Surgical Pain The use of deracoxib for postoperative pain is supported by robust clinical evidence, particularly for soft tissue and dental surgeries. ### Soft Tissue Surgery A pivotal prospective, randomized, blinded, placebo-controlled multi-center study evaluated the efficacy and safety of deracoxib for controlling pain after soft tissue surgery in dogs [2]. In this study, dogs received either deracoxib (1-2 mg/kg/day) or a placebo. The treatment was administered preoperatively and continued once daily for two days after surgery. The results were striking: only 2 of 16 dogs treated with deracoxib required rescue analgesia, compared to 9 of 16 dogs that received the placebo. This difference was statistically significant (P = .0091), demonstrating that perioperative deracoxib significantly improves analgesia in the postoperative period [2]. ### Dental Surgery Similar results were found in a study focusing on dental surgery, a procedure known to cause significant pain and inflammation [3]. In this trial, dogs undergoing dental extractions were premedicated with butorphanol and then randomly assigned to receive either deracoxib (1-2 mg/kg/day) or a placebo for three days. The study found that only 4 of 27 deracoxib-treated dogs (14.8%) required rescue pain medication, whereas 20 of 30 placebo-treated dogs (66.7%) did. This difference was also highly significant (P = 0.0006), confirming the effectiveness of deracoxib in managing dental postoperative pain [3]. ### How the Dose Is Determined Your veterinarian calculates the precise dose of Deramaxx based on your dog's body weight. The target dose range is 1 to 2 mg/kg. For example, a 10 kg (22 lb) dog might receive a dose between 10 mg and 20 mg once daily. The commercially available chewable tablets come in various strengths, and your vet will prescribe the tablet size that most closely matches the calculated dose. It is essential to give the exact amount prescribed and to complete the full course of medication as directed, even if your dog seems to be feeling better. ## Safety, Tolerability, and Adverse Effects While deracoxib is an effective analgesic, it is not without potential side effects. Understanding these risks is crucial for any owner administering this medication. ### Gastrointestinal Safety The most common adverse effects associated with deracoxib are gastrointestinal. In the dental surgery study, 8 of 31 deracoxib-treated dogs (26%) had reported adverse events, compared to 6 of 31 in the placebo group [3]. These events can include vomiting, diarrhoea, and decreased appetite. More serious gastrointestinal complications can occur. A case series described three dogs that developed proximal duodenal perforation and subsequent septic peritonitis following deracoxib administration at doses ranging from 2 to 3 mg/kg [4]. Two of these dogs were receiving the approved labeled dosage. This highlights that even at correct doses, deracoxib can cause severe, life-threatening ulceration in susceptible individuals [4][5]. A recent study confirmed that dogs receiving COX-2 sparing NSAIDs at recommended doses are at risk of severe GI ulceration, with the duodenum being a common site [5]. However, compared to older, non-selective NSAIDs, deracoxib has a better gastric safety profile. A study comparing deracoxib (1.5 mg/kg QD) to buffered aspirin (25 mg/kg PO q8h) over 28 days found no significant difference in endoscopically detectable gastric injury between the deracoxib and placebo groups, while aspirin caused significantly more gastric damage [7]. ### Renal and Hepatic Effects As with all NSAIDs, there is a potential for renal and hepatic effects. Target animal safety studies found a dose-dependent trend towards increased blood urea nitrogen (BUN) in treated dogs, although mean values remained within the reference range at labeled doses [1]. Histopathology revealed focal renal tubular degeneration/regeneration in some dogs receiving 6 mg/kg/day or more, which is three times the recommended postoperative dose. Focal renal papillary necrosis was seen in a few dogs receiving 8 to 10 mg/kg/day over six months [1]. This underscores the importance of using the lowest effective dose for the shortest necessary duration and avoiding use in dogs with pre-existing kidney disease. ### Effects on Platelet Function Deracoxib has a mild effect on platelet function. Studies have shown that therapeutic doses of deracoxib can cause a mild decrease in platelet aggregation and prolong closure times on some platelet function tests [8][9]. While this effect is generally considered clinically insignificant in healthy dogs, it is a factor your veterinarian will consider, especially if your dog has a bleeding disorder or is undergoing a procedure with a high risk of hemorrhage [8][9]. ## High-Risk Groups and Contraindications Certain dogs are at a higher risk of experiencing adverse effects from deracoxib. It is vital to discuss your dog's complete medical history with your veterinarian before starting this medication. - **Dogs with Gastrointestinal Disease:** Dogs with a history of inflammatory bowel disease, gastritis, or previous GI ulceration are at a significantly higher risk [4][5]. - **Dogs with Kidney or Liver Disease:** Because deracoxib is metabolized by the liver and can affect renal blood flow, it should be used with extreme caution or avoided in dogs with hepatic or renal insufficiency [1]. - **Dogs on Other Medications:** The concurrent use of deracoxib with other NSAIDs or corticosteroids significantly increases the risk of severe gastrointestinal ulceration and perforation. A recent study found that all dogs receiving two NSAIDs concurrently experienced full-thickness perforation [5]. This combination must be strictly avoided. - **Dehydrated or Hypotensive Dogs:** Dogs that are dehydrated or have low blood pressure (e.g., from blood loss during surgery) have reduced renal blood flow, making them more susceptible to NSAID-induced kidney injury. ## Administration Guidelines and Owner Instructions Proper administration is key to both the efficacy and safety of Deramaxx. 1. **Give with Food:** Administer the medication with or after a meal to help buffer the stomach and reduce the risk of gastrointestinal upset. 2. **Use Exact Dose:** Use the measuring device or tablet strength provided by your veterinarian. Do not guess or split tablets unless specifically instructed to do so. 3. **Complete the Course:** Even if your dog appears to be pain-free, complete the full 3-day course as prescribed to manage underlying inflammation. 4. **Monitor Closely:** Observe your dog for any signs of adverse effects, including vomiting, diarrhoea, changes in appetite, dark or tarry stools, yellowing of the gums or skin (jaundice), increased thirst or urination, or lethargy. 5. **Do Not Combine:** Never give your dog another NSAID (e.g., carprofen, meloxicam, aspirin) or a corticosteroid (e.g., prednisone) while they are taking Deramaxx, unless explicitly directed by your veterinarian. ## Unsafe Home Remedies and Over-the-Counter Medications It is a common but dangerous misconception that human NSAIDs are safe for dogs. You should never give your dog over-the-counter human pain relievers such as ibuprofen (Advil, Motrin), naproxen (Aleve), or acetaminophen (Tylenol) without direct veterinary supervision. These drugs can be highly toxic to dogs, causing severe gastrointestinal ulcers, kidney failure, and liver damage. Similarly, do not give your dog aspirin, as it carries a high risk of GI bleeding. When it comes to pain management, always rely on the medications prescribed by your veterinarian. ## Prevention and Monitoring for Complications The best way to prevent complications from deracoxib is to use it judiciously and with full knowledge of your dog's health status. - **Pre-Surgical Screening:** Your veterinarian will likely recommend blood work before surgery, especially in senior dogs, to establish a baseline for kidney and liver function. - **Post-Surgical Observation:** In the days following surgery, monitor your dog's appetite, energy level, and bathroom habits closely. A sudden decrease in appetite or the onset of vomiting are red flags. - **Follow-Up:** Your veterinarian may recommend a follow-up appointment to assess your dog's recovery and ensure the medication is being well-tolerated. ## Prognosis and Recovery When used correctly, deracoxib is highly effective at controlling postoperative pain, which facilitates a smoother and faster recovery. In the clinical studies, dogs treated with deracoxib had significantly better pain control, meaning they were more comfortable and likely to rest and begin moving normally sooner [2][3]. The prognosis for a full recovery is excellent for most dogs, provided the medication is used as directed and any adverse effects are caught early. ## Limitations and When to Contact a Veterinarian This guide provides a comprehensive overview of deracoxib use for post-surgical pain, but it cannot predict how your individual dog will respond. Breed, age, genetic predispositions, and pre-existing health conditions all play a role in how a dog metabolizes and tolerates any medication. The information presented here is based on clinical trials and case reports, but it does not replace the professional judgment of your veterinarian, who has the benefit of examining your dog in person and reviewing their full medical history. **Contact your veterinarian immediately if you observe any of the following emergency red flags:** - **Severe or repeated vomiting, especially if it contains blood.** - **Black, tarry, or bloody stools (a sign of gastrointestinal bleeding).** - **Sudden loss of appetite lasting more than 24 hours.** - **Severe lethargy, weakness, or collapse.** - **Jaundice (yellowing of the gums, eyes, or skin).** - **Changes in drinking or urinating habits.** - **Signs of abdominal pain (e.g., restlessness, panting, or a tucked-up abdomen).** ## The Pharmacology of Deracoxib: What Happens Inside Your Dog's Body Understanding how deracoxib works at a cellular level helps owners appreciate both its benefits and its limitations. Deracoxib belongs to the coxib class of NSAIDs, which were developed to address the gastrointestinal toxicity seen with older, non-selective NSAIDs that block both COX-1 and COX-2 enzymes. The COX-1 enzyme is constitutively expressed in many tissues, including the stomach lining, kidneys, and platelets, where it produces prostaglandins that protect the gastric mucosa, maintain renal blood flow, and support normal clotting. COX-2, by contrast, is induced at sites of inflammation and injury, generating prostaglandins that sensitize pain receptors and drive the inflammatory cascade [1][6]. The selectivity of deracoxib for COX-2 over COX-1 is dose-dependent. At the labeled postoperative dose of 1 to 2 mg/kg, deracoxib demonstrates meaningful COX-2 selectivity, which theoretically preserves gastric protective prostaglandins while reducing pain and inflammation at the surgical site [1]. However, this selectivity is not absolute. As the dose increases, the margin between COX-2 and COX-1 inhibition narrows, and the risk of gastrointestinal injury rises correspondingly. This is why the target animal safety studies observed renal tubular degeneration at doses of 6 mg/kg or higher, three times the recommended postoperative dose, and why the label carries explicit warnings about exceeding the approved dose range [1]. The clinical relevance of COX-2 selectivity extends beyond the stomach. Prostaglandins produced by COX-2 also play a role in renal hemodynamics, particularly in states of reduced blood flow. When a dog is dehydrated, hypotensive, or has pre-existing kidney disease, the kidneys rely on prostaglandin-mediated vasodilation to maintain adequate perfusion. By inhibiting COX-2, deracoxib can reduce this compensatory mechanism, potentially leading to decreased renal blood flow and, in susceptible individuals, acute kidney injury [1]. This physiological reality underpins the strong recommendation to ensure dogs are well-hydrated before and after surgery and to avoid deracoxib in dogs with known renal compromise. Another important pharmacological consideration is the metabolism and elimination of deracoxib. The drug is extensively metabolized in the liver, primarily through glucuronidation and oxidation pathways. This means that dogs with hepatic dysfunction may clear the drug more slowly, leading to higher and more prolonged systemic exposure. Conversely, because deracoxib is highly protein-bound, dogs with low serum albumin (a common finding in chronic illness or malnutrition) may have higher free drug concentrations, increasing the risk of toxicity. These pharmacokinetic variables are why veterinarians often recommend baseline blood work before surgery, particularly in senior dogs or those with a history of systemic disease [1]. ## The Diagnostic Workup: How Your Veterinarian Determines If Deracoxib Is Safe Before prescribing deracoxib, your veterinarian should perform a thorough assessment that goes beyond a simple weight-based dose calculation. This pre-treatment evaluation is designed to identify dogs at increased risk of NSAID-related complications and to establish baseline values against which future changes can be measured. The cornerstone of this workup is a complete blood count (CBC) and serum biochemistry panel. The biochemistry panel provides critical information about kidney function (blood urea nitrogen, creatinine, symmetric dimethylarginine or SDMA), liver health (alanine aminotransferase, alkaline phosphatase, bilirubin), and total protein/albumin levels. A dog with elevated kidney values or evidence of chronic kidney disease may not be a candidate for deracoxib, or the veterinarian may choose a different analgesic strategy altogether. Similarly, elevated liver enzymes may indicate hepatic dysfunction that could impair drug metabolism and increase the risk of adverse effects [1]. In addition to laboratory testing, the veterinarian will take a detailed history focusing on any prior episodes of gastrointestinal upset, known food allergies or sensitivities, and current medications. This is particularly important because many dogs receive multiple medications in the perioperative period, including antibiotics, sedatives, and other analgesics. The veterinarian needs to know about every product the dog receives, including over-the-counter supplements and flea/tick preventives, to rule out potential drug interactions. For example, concurrent use of corticosteroids, even topical preparations, can dramatically increase the risk of gastrointestinal ulceration when combined with deracoxib [5]. For dogs with a history of gastrointestinal disease, such as inflammatory bowel disease, chronic gastritis, or previous ulceration, the veterinarian may recommend additional diagnostic testing before using deracoxib. This could include abdominal ultrasound to assess the stomach and intestinal walls, or in some cases, endoscopy to directly visualize the mucosa. While these advanced diagnostics are not necessary for every dog, they are appropriate when there is a clinical suspicion of pre-existing GI pathology that could be exacerbated by NSAID therapy [4][5]. The physical examination also plays a role in the safety assessment. The veterinarian will evaluate the dog's hydration status by checking skin turgor, mucous membrane moisture, and capillary refill time. A dog that is dehydrated, whether from preoperative fasting, vomiting, or blood loss during surgery, has reduced renal blood flow and is more vulnerable to NSAID-induced kidney injury. In such cases, the veterinarian may delay the first dose of deracoxib until the dog is rehydrated with intravenous fluids, or may choose a different class of analgesic for the immediate postoperative period. ## The Multimodal Approach: Why Deracoxib Is Often Part of a Larger Pain Plan Modern veterinary anesthesia and analgesia have moved away from relying on a single drug for pain control. Instead, the standard of care is multimodal analgesia, which uses multiple drug classes with different mechanisms of action to achieve better pain relief with lower doses of each individual drug, thereby reducing the risk of side effects. In the perioperative setting, deracoxib is frequently combined with opioids, local anesthetics, and other adjunctive agents. For example, a dog undergoing dental extractions might receive an opioid such as butorphanol or hydromorphone before surgery, a local nerve block during the procedure, and deracoxib after surgery [3]. Each of these interventions targets pain through a different pathway: opioids act on central opioid receptors, local anesthetics block nerve conduction, and deracoxib reduces peripheral inflammation. The result is more complete pain control than any single drug could achieve alone. This multimodal approach also allows for opioid-sparing effects. By providing baseline analgesia with deracoxib, the veterinarian may be able to use lower doses of opioids, which reduces the risk of opioid-related side effects such as sedation, constipation, and respiratory depression. In the soft tissue surgery study, dogs that received deracoxib required significantly less rescue analgesia than those on placebo, demonstrating that the NSAID provided meaningful pain relief that reduced the need for additional interventions [2]. Owners should understand that their dog may be sent home with more than one pain medication. It is not uncommon for a veterinarian to prescribe deracoxib for inflammation and a separate medication, such as gabapentin or tramadol, for neuropathic or breakthrough pain. These combinations are carefully selected to be safe and synergistic. However, the owner must be vigilant about not adding any other NSAID or corticosteroid to the regimen, as this is the most common cause of severe, life-threatening gastrointestinal complications [5]. ## Recognizing Pain in Dogs: A Guide for Owners One of the most challenging aspects of postoperative care is recognizing when a dog is in pain. Dogs are evolutionarily programmed to hide signs of weakness and discomfort, a survival instinct that persists even in domesticated pets. This means that by the time a dog is obviously vocalizing or limping, the pain may already be significant. Subtle signs of pain in dogs include changes in behavior and routine. A dog that is normally social may become withdrawn or irritable, avoiding interaction with family members. A dog that is normally active may become reluctant to move, climb stairs, or jump onto furniture. Changes in posture are also telling: a painful dog may stand with a hunched back, hold its head low, or adopt a "praying" position with the front legs down and hindquarters up, which can indicate abdominal pain. Panting, trembling, and restlessness are other common signs, particularly if they are out of proportion to the ambient temperature or activity level. Facial expression is another important indicator. Dogs in pain often have a tense facial expression with a furrowed brow, dilated pupils, and a tight mouth. They may also lick or chew at the surgical site, which can indicate both pain and the presence of sutures or staples. Changes in appetite and drinking habits are also significant. A dog that refuses food or water after surgery may be experiencing nausea, which can be a side effect of both anesthesia and NSAIDs. The veterinarian will assess pain using validated scoring systems, such as the Glasgow Composite Measure Pain Scale or the Colorado State University Canine Acute Pain Scale. These tools evaluate multiple parameters, including posture, vocalization, attention to the wound, and interaction with observers. Owners can use similar observational frameworks at home, noting any deviation from their dog's normal behavior and reporting it to the veterinarian. It is important to remember that the absence of obvious pain signs does not mean the dog is pain-free. Many dogs are stoic and will tolerate significant discomfort without overt vocalization. This is why the prophylactic use of deracoxib in the perioperative period is so valuable: it provides a baseline level of analgesia that prevents pain from becoming established, rather than trying to chase and control pain once it has already developed [2][3]. ## The Importance of Timing: Preoperative Versus Postoperative Administration The clinical trials that established the efficacy of deracoxib for postoperative pain used a specific dosing protocol: the first dose was administered preoperatively, and subsequent doses were given once daily for two days after surgery [2][3]. This timing is not arbitrary; it reflects the concept of preemptive analgesia, which is the administration of pain medication before the surgical stimulus occurs. The rationale for preemptive analgesia is that surgical trauma triggers a cascade of inflammatory mediators and central sensitization that amplifies pain signals. By blocking the COX-2 enzyme before surgery, deracoxib can reduce the initial inflammatory response, preventing the amplification of pain signals and reducing the overall pain burden in the postoperative period. Studies in both human and veterinary medicine have shown that preemptive analgesia can reduce postoperative pain scores, decrease the need for rescue analgesia, and shorten recovery times [2][3]. In practice, this means that your dog may receive the first dose of deracoxib at the veterinary hospital, either as part of the pre-anesthetic protocol or immediately after the procedure while still under anesthesia. The owner's responsibility is to continue the medication at home according to the prescribed schedule. It is critical not to skip doses or extend the interval between doses, as this can allow pain to break through and become more difficult to control. If a dose is missed, the general recommendation is to give it as soon as it is remembered, unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped and the regular schedule resumed. Owners should never double up on doses to compensate for a missed one, as this increases the risk of adverse effects without providing additional pain relief. ## Special Populations: Puppies, Seniors, and Dogs with Comorbidities The safety and efficacy of deracoxib have been established primarily in adult dogs, and the labeled indications reflect this. However, in clinical practice, deracoxib is sometimes used in younger and older dogs, and the veterinarian must weigh the potential benefits against the increased risks in these populations. Puppies, particularly those under six months of age, have immature hepatic and renal enzyme systems that may metabolize and clear drugs differently than adult dogs. The safety of deracoxib in very young puppies has not been extensively studied, and the target animal safety data were generated in adult dogs [1]. For this reason, many veterinarians are cautious about using deracoxib in puppies, particularly for elective procedures. If deracoxib is used in a puppy, it is typically at the lower end of the dose range and for the shortest possible duration, with close monitoring for any signs of adverse effects. Senior dogs present a different set of challenges. Aging is associated with a decline in renal function, hepatic metabolism, and gastrointestinal mucosal integrity. A senior dog may have subclinical kidney disease that is not yet apparent on routine blood work, making them more vulnerable to NSAID-induced renal injury. Similarly, age-related changes in the gastrointestinal tract can increase the risk of ulceration. For these reasons, the veterinarian may recommend additional diagnostic testing before using deracoxib in a senior dog, such as a urinalysis to assess urine concentrating ability or an abdominal ultrasound to evaluate organ structure [1]. Dogs with comorbidities require individualized treatment plans. For example, a dog with osteoarthritis may already be receiving an NSAID for chronic pain. If that dog requires surgery, the veterinarian must decide whether to continue the existing NSAID, switch to deracoxib, or use a different analgesic strategy. The concurrent use of two NSAIDs is absolutely contraindicated, as it dramatically increases the risk of severe gastrointestinal ulceration and perforation [5]. In most cases, the veterinarian will discontinue the chronic NSAID for a washout period before surgery and then use a single NSAID, such as deracoxib, for the perioperative period. Dogs with cardiac disease also require special consideration. Many cardiac medications, such as ACE inhibitors and diuretics, can affect renal blood flow and electrolyte balance. The addition of an NSAID like deracoxib can further compromise renal perfusion, particularly in dogs with congestive heart failure. The veterinarian may need to adjust the cardiac medications, monitor kidney values more frequently, or choose a different analgesic approach in these patients. ## The Evidence Base: What the Studies Show and What They Do Not The use of deracoxib for postoperative pain is supported by a solid evidence base, but it is important for owners to understand both the strengths and the limitations of this evidence. The two pivotal studies that support the soft tissue and dental surgery indications were prospective, randomized, blinded, and placebo-controlled, which are the gold standard for clinical research [2][3]. These studies demonstrated statistically significant improvements in pain control with deracoxib compared to placebo, with a relatively low incidence of adverse events. However, these studies had relatively small sample sizes. The soft tissue surgery study enrolled 32 dogs (16 per group), and the dental surgery study enrolled 62 dogs (31 per group) [2][3]. While these sample sizes were sufficient to detect large differences in the need for rescue analgesia, they are too small to detect rare but serious adverse events. For example, if a particular complication occurs in 1% of dogs, a study of 32 dogs would have only a 28% chance of detecting even one case. This is why post-marketing surveillance and case reports are so important for understanding the full safety profile of any drug. The case series describing duodenal perforation in dogs receiving deracoxib is a critical piece of safety data [4]. This report documented three dogs that developed proximal duodenal perforation and septic peritonitis, two of which were receiving the approved labeled dosage. This case series serves as a powerful reminder that even correctly dosed NSAIDs can cause life-threatening complications in susceptible individuals. The fact that the duodenum was the site of perforation is notable, as this region of the gastrointestinal tract is a common site for NSAID-induced injury in dogs [5]. Another important limitation of the clinical trial data is the duration of treatment. The pivotal studies evaluated deracoxib for three days of therapy [2][3]. While this is appropriate for acute postoperative pain, it does not provide information about the safety of longer-term use. For chronic conditions like osteoarthritis, deracoxib is approved for longer durations, but the safety data for extended use come from separate studies and target animal safety trials [1]. Owners should never extend the duration of deracoxib therapy beyond what the veterinarian has prescribed, as the risk of adverse effects increases with cumulative exposure. ## Owner Observation: What to Watch For and When to Act The days following surgery are a critical period for monitoring your dog's recovery and response to medication. While the veterinarian will provide specific instructions, there are general principles that apply to all dogs receiving deracoxib. The most common adverse effects are gastrointestinal, and they typically manifest within the first few days of treatment. Vomiting, diarrhoea, and decreased appetite are the most frequently reported signs [2][3][4]. Mild, transient gastrointestinal upset may resolve on its own, but any vomiting that occurs more than once, or that is accompanied by other signs such as lethargy or abdominal pain, warrants immediate veterinary attention. More concerning signs include black, tarry stools (melena), which indicate digested blood in the gastrointestinal tract, and hematemesis, which is vomiting of fresh or digested blood. These signs suggest gastrointestinal ulceration or perforation and require emergency veterinary care. Similarly, jaundice, which appears as yellowing of the gums, eyes, or skin, indicates liver dysfunction and requires immediate evaluation. Changes in drinking and urinating habits can signal kidney problems. Increased thirst (polydipsia) and increased urination (polyuria) may indicate that the kidneys are struggling to concentrate urine, while decreased urination or complete cessation of urination is a medical emergency. Owners should monitor their dog's water intake and the frequency and volume of urination, particularly in the first few days after surgery. Behavioral changes are also important. A dog that becomes increasingly lethargic, weak, or unresponsive may be experiencing a serious adverse reaction. Collapse or seizures require immediate emergency care. Conversely, a dog that becomes restless, paces, or seems unable to get comfortable may be in pain, and the veterinarian should be consulted about whether additional analgesia is needed. Owners should also monitor the surgical incision site itself. Redness, swelling, discharge, or dehiscence (opening of the incision) can indicate infection or poor healing, which may require additional treatment. While these complications are not directly caused by deracoxib, they can affect the overall recovery process and may influence the pain management plan. ## The Role of Nutrition and Hydration During Recovery Proper nutrition and hydration are essential components of postoperative recovery, and they also play a role in the safe use of deracoxib. Administering the medication with food is recommended to reduce the risk of gastrointestinal upset. The food acts as a buffer, coating the stomach lining and reducing direct contact between the drug and the gastric mucosa. Beyond the immediate administration of the medication, maintaining good hydration is critical for kidney health. As discussed earlier, NSAIDs can reduce renal blood flow, and this effect is exacerbated by dehydration. Owners should ensure that fresh, clean water is always available and should encourage their dog to drink, particularly if the dog is reluctant to eat or is recovering from anesthesia. A bland diet may be recommended for the first day or two after surgery, particularly if the dog has a sensitive stomach. Boiled chicken and rice, or a prescription gastrointestinal diet, can be easier to digest than regular commercial food. However, owners should not make significant dietary changes without consulting the veterinarian, as sudden changes can themselves cause gastrointestinal upset. Nutritional support is also important for wound healing. Protein is essential for tissue repair, and dogs that are not eating adequately may have delayed healing and a higher risk of complications. If a dog refuses food for more than 24 hours after surgery, the veterinarian should be notified, as this may indicate inadequate pain control, nausea, or a more serious complication. ## The Financial and Logistical Considerations of Postoperative Pain Management Owners should be prepared for the financial and logistical aspects of postoperative pain management. Deracoxib is a prescription medication, and the cost will vary depending on the dose, the number of tablets prescribed, and the pharmacy or veterinary hospital where it is purchased. Owners should discuss the cost of the medication with the veterinarian before the surgery so that there are no surprises. It is also important to understand that the cost of the medication is only one component of the overall surgical expense. The pre-surgical blood work, the surgery itself, anesthesia, hospitalization, and any follow-up visits all contribute to the total cost. Some pet insurance policies cover a portion of these expenses, and owners should check their policy to understand what is covered. Logistically, owners need to plan for the postoperative period. This may involve taking time off work to care for the dog, arranging for someone to check on the dog during the day, and ensuring that the home environment is safe and comfortable for a recovering animal. The dog should have a quiet, warm place to rest, away from other pets and young children. Access to the outdoors for bathroom breaks should be convenient, but the dog should not be allowed to run, jump, or engage in vigorous activity until the veterinarian clears them for normal exercise. ## The Importance of Follow-Up Care The end of the deracoxib prescription does not mean the end of the recovery process. Follow-up care is essential to ensure that the dog is healing properly and that there are no delayed complications from the surgery or the medication. The veterinarian will typically schedule a follow-up appointment within 10 to 14 days after surgery to assess the incision site, remove sutures or staples if needed, and evaluate the dog's overall recovery. This is also an opportunity to discuss any concerns the owner may have about the dog's appetite, energy level, or behavior. In some cases, the veterinarian may recommend repeat blood work at the follow-up visit, particularly if the dog is a senior or has pre-existing health conditions. This allows the veterinarian to confirm that kidney and liver function have returned to baseline and that there are no lingering effects from the NSAID therapy. Owners should also be aware that some complications can occur weeks after surgery. For example, a dog that develops a delayed gastrointestinal ulcer may not show signs until the deracoxib has been discontinued. If the owner notices any of the emergency red flags discussed earlier, they should contact the veterinarian immediately, even if the medication course has been completed. ## The Broader Context: Deracoxib in the Landscape of Veterinary Pain Management Deracoxib is one of several NSAIDs approved for use in dogs, and it is helpful to understand where it fits in the broader landscape of veterinary pain management. Other commonly used canine NSAIDs include carprofen, meloxicam, firocoxib, and robenacoxib. Each of these drugs has a slightly different COX-1/COX-2 selectivity profile, half-life, and safety record, and the choice between them is often based on the veterinarian's clinical experience, the specific procedure, and the individual dog's health status. Carprofen is one of the most widely used NSAIDs in veterinary medicine and has a long track record of safety and efficacy. It is less COX-2 selective than deracoxib, meaning it has a somewhat higher potential for gastrointestinal side effects, but it is generally well-tolerated. Meloxicam is available in both injectable and oral formulations, which makes it convenient for perioperative use. Firocoxib is another coxib-class NSAID that is similar to deracoxib in its selectivity profile. The choice between these drugs is not always straightforward. Some studies have compared the relative safety of different NSAIDs, but the results are not always consistent, and the clinical significance of small differences in COX-2 selectivity is debated. What is clear is that no NSAID is completely safe, and the risk of adverse effects must be weighed against the benefits of pain relief for each individual dog [5]. Owners should feel empowered to ask their veterinarian about the choice of NSAID and the reasons behind it. A good veterinarian will be able to explain the rationale for choosing deracoxib over another drug, taking into account the dog's age, health status, and the type of surgery being performed. This open communication is essential for building trust and ensuring the best possible outcome for the dog. ## Preparing for the Veterinary Visit: Questions to Ask Before your dog's surgery, it is wise to prepare a list of questions to ask the veterinarian about pain management. This ensures that you have all the information you need to provide the best possible care for your dog during the recovery period. Key questions to consider include: - What pain medication will my dog receive, and how is the dose determined? - When will the first dose be given, and how long will the medication course last? - What are the most common side effects I should watch for, and which signs require immediate veterinary attention? - Can I give my dog any other medications, including over-the-counter products or supplements, while they are on deracoxib? - What should I do if my dog refuses to eat or seems unusually lethargic? - Are there any activity restrictions during the recovery period, and when can my dog resume normal exercise? - When should I schedule a follow-up appointment, and will any additional testing be needed? Asking these questions demonstrates that you are an engaged and informed owner, and it helps the veterinarian tailor the pain management plan to your dog's specific needs. It also ensures that you are not caught off guard by any unexpected developments during the recovery period. ## The Psychological and Emotional Aspects of Postoperative Care The postoperative period can be stressful for both the dog and the owner. The dog may be disoriented from anesthesia, uncomfortable from the surgery, and confused by the changes in its routine. The owner may be anxious about the dog's recovery, worried about the cost of treatment, and uncertain about how to provide the best care. It is important for owners to remain calm and patient during this time. Dogs are highly attuned to their owners' emotional states, and a calm, reassuring presence can help reduce the dog's stress and anxiety. Gentle handling, soft speech, and a quiet environment can all contribute to a smoother recovery. Owners should also be prepared for the possibility that the dog's behavior may be different than usual. A normally independent dog may become clingy and seek constant attention, while a normally affectionate dog may become withdrawn and want to be left alone. These behavioral changes are normal responses to stress and discomfort, and they typically resolve as the dog recovers. If the owner is feeling overwhelmed or uncertain about any aspect of the dog's care, they should not hesitate to contact the veterinary hospital. The veterinary team is there to support both the dog and the owner, and they can provide guidance on everything from medication administration to behavioral management. ## The Prognosis for Full Recovery The prognosis for a full recovery after surgery is excellent for the vast majority of dogs, particularly when pain is well-managed with appropriate medications like deracoxib. The clinical trials demonstrated that dogs receiving deracoxib had significantly better pain control than those receiving placebo, which translates into a more comfortable and less stressful recovery experience [2][3]. Effective pain control has benefits that extend beyond comfort. Dogs that are comfortable are more likely to rest, which is essential for tissue healing. They are also more likely to eat and drink, which provides the nutrients and hydration needed for recovery. Early mobilization, when appropriate, can help prevent muscle atrophy and joint stiffness, leading to a faster return to normal function. However, the prognosis is not guaranteed, and complications can occur. The risk of serious adverse events from deracoxib, such as gastrointestinal perforation or kidney injury, is low but not zero [4][5]. Owners who are vigilant about monitoring their dog for signs of complications and who seek prompt veterinary care when concerns arise can significantly improve the chances of a positive outcome. Ultimately, the key to a successful recovery is a partnership between the owner and the veterinary team. By understanding how deracoxib works, how to administer it safely, and what to watch for during the recovery period, owners can play an active role in ensuring their dog's comfort and well-being. The information in this guide is intended to support that partnership, but it is not a substitute for professional veterinary advice. Always consult with your veterinarian for any questions or concerns about your dog's health and medication regimen. ## Frequently Asked Questions ### What is the exact dose of Deramaxx for my dog after surgery? The standard dose is 1 to 2 mg per kilogram of body weight, given once daily. Your veterinarian will calculate the precise amount based on your dog's weight and the specific product formulation. ### How long should my dog take Deramaxx after surgery? In clinical trials for soft tissue and dental surgery, deracoxib was given for a total of 3 days: once preoperatively and then once daily for two days after surgery. Your vet may adjust this based on the procedure and your dog's needs. ### Can I give Deramaxx with other pain medications? You should never give another NSAID or a corticosteroid with Deramaxx, as this combination is highly dangerous and can cause severe gastrointestinal ulcers. However, your veterinarian may prescribe other classes of pain relievers (e.g., opioids) to be used alongside it. ### What are the most common side effects of Deramaxx in dogs? The most common side effects include vomiting, diarrhoea, and decreased appetite. More serious, though less common, side effects include gastrointestinal ulceration and kidney issues. ### What should I do if I miss giving my dog a dose of Deramaxx? If you miss a dose, give it as soon as you remember. However, if it is almost time for the next scheduled dose, skip the missed dose and resume the normal schedule. Do not give a double dose to make up for a missed one. ### Is Deramaxx safe for all dogs? No, Deramaxx is not safe for all dogs. It should be used with extreme caution or avoided in dogs with pre-existing kidney, liver, or gastrointestinal disease, and in dogs that are dehydrated or have low blood pressure. ### Can Deramaxx cause stomach ulcers in dogs? Yes, deracoxib can cause gastrointestinal ulceration and even perforation, as documented in several studies. While the risk is lower than with older NSAIDs, it is a serious potential side effect that requires immediate veterinary attention if signs appear. ### How does Deramaxx compare to other NSAIDs like carprofen? Both are effective NSAIDs, but they are different drugs. Deracoxib is a more selective COX-2 inhibitor than carprofen. Studies show that both can affect platelet function, and both carry a risk of GI ulceration. The choice between them depends on your veterinarian's preference and your dog's specific health profile. ## Limitations and When to Contact a Veterinarian This guide provides a comprehensive overview of deracoxib use for post-surgical pain, but it cannot predict how your individual dog will respond. Breed, age, genetic predispositions, and pre-existing health conditions all play a role in how a dog metabolizes and tolerates any medication. The information presented here is based on clinical trials and case reports, but it does not replace the professional judgment of your veterinarian, who has the benefit of examining your dog in person and reviewing their full medical history. **Contact your veterinarian immediately if you observe any of the following emergency red flags:** - **Severe or repeated vomiting, especially if it contains blood.** - **Black, tarry, or bloody stools (a sign of gastrointestinal bleeding).** - **Sudden loss of appetite lasting more than 24 hours.** - **Severe lethargy, weakness, or collapse.** - **Jaundice (yellowing of the gums, eyes, or skin).** - **Changes in drinking or urinating habits.** - **Signs of abdominal pain (e.g., restlessness, panting, or a tucked-up abdomen).** ## Related Clinical & Scientific Guides * [Drontal Plus Dewormer: Broad-Spectrum Dose Guide by Weight](/knowledge/veterinary-medicine/calculators-clinical-tools/drontal-plus-dewormer-broad-spectrum-dose-guide-by-weight) * [Panacur Fenbendazole Dewormer: Dog Fecal Parasite Treatment Schedule](/knowledge/veterinary-medicine/calculators-clinical-tools/panacur-fenbendazole-dewormer-dog-fecal-parasite-treatment-schedule) * [Prednisolone for Cats: Feline Safe Steroid Dose and Autoimmune](/knowledge/veterinary-medicine/calculators-clinical-tools/prednisolone-for-cats-feline-safe-steroid-dose-and-autoimmune)